{"id":"W2012876387","doi":"10.1038/leu.2012.329","title":"PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia","year":2012,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto General Hospital; York University; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Chronic lymphocytic leukemia; CD5; Peroxisome proliferator-activated receptor; Downregulation and upregulation; Biology; Lipoprotein lipase; Cancer research; Peroxisome proliferator-activated receptor alpha; Internal medicine; Endocrinology; Receptor; Leukemia; Nuclear receptor; Immunology; Adipose tissue; Antibody; Medicine; Transcription factor; Biochemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005043088,0.0003008363,0.0004171323,0.0004882509,0.0004317091,0.0008293035,0.0002438021,0.0004748543,0.004980216],"category_scores_gemma":[0.0002227738,0.0001370712,0.0003322582,0.0007204328,0.000437506,0.0003351053,0.000413891,0.001382991,0.001496027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005835476,"about_ca_system_score_gemma":0.000749639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004552545,"about_ca_topic_score_gemma":0.001124327,"domain_scores_codex":[0.9998316,0.00004431397,0.00001514464,0.00001695142,0.00004263852,0.00004934687],"domain_scores_gemma":[0.9998735,0.00002081447,0.0000365634,0.00001185527,0.0000268192,0.00003032892],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007356495,0.001014994,0.009040458,0.002293047,0.0002700792,0.001485974,0.0002525485,0.0008471227,0.2978789,0.01796296,0.03588635,0.6257111],"study_design_scores_gemma":[0.001954941,0.00561964,0.02185358,0.0005716084,0.0005271782,0.003907425,0.0008968399,0.0007228926,0.1230061,0.008386613,0.8324993,0.00005397383],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.4214568,0.439716,0.008778448,0.04253404,0.005769385,0.0002599634,0.002150453,0.0006027156,0.07873224],"genre_scores_gemma":[0.7416419,0.1796884,0.007290476,0.005988714,0.002147036,0.0002576248,0.002228815,0.00006493661,0.06069215],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.004980216,"threshold_uncertainty_score":0.01666045,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03439344377669197,"score_gpt":0.3255027107052507,"score_spread":0.2911092669285588,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}